Jazz Pharmaceuticals JAZZ Capital redemption reserve
Capital redemption reserve at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:CapitalRedemptionReserve.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's capital redemption reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's capital redemption reserve?
- Jazz Pharmaceuticals (JAZZ) reported capital redemption reserve of $500K in Q1 2026.
- How has Jazz Pharmaceuticals's capital redemption reserve changed year-over-year?
- Jazz Pharmaceuticals's capital redemption reserve increased by 5.7% year-over-year, from $473K to $500K.
- What is the long-term trend for Jazz Pharmaceuticals's capital redemption reserve?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's capital redemption reserve has grown at a 1.2% compound annual growth rate (CAGR), from $472K to $500K.
- What does capital redemption reserve mean?
- A restricted reserve created to maintain capital integrity after a share buyback.
- How do you interpret capital redemption reserve?
- An increase indicates the company has utilized profits to retire shares, effectively returning capital to shareholders.
- How does capital redemption reserve compare across companies?
- Common in jurisdictions with strict capital maintenance rules; less common in standard US GAAP reporting.